Glenmark Life Sciences Limited (GLS)
₹1,015
INR+0.60(+0.06%)
As of June 6, 2025 6:28:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹13304.65 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹12854.51 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
31.45
Forward P/E
Price to Earnings ratio based on forecasted earnings
22.31
PEG Ratio
Price/Earnings to Growth ratio
22.31
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
6.03
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
55.55%
Operating Margin
Operating income as a percentage of revenue
23.53%
Return on Equity
Net income as a percentage of shareholders' equity
17.18%
Revenue (TTM)
Total revenue over trailing 12 months
₹2204.90 Cr-14.899999999999999%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹653.21 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹34.48-19.7%
Balance Sheet
Total Cash
Total cash and short-term investments
₹446.29 Cr
Total Debt
Total short-term and long-term debt
₹15.98 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
0.63%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹819.05 - ₹1335.1
Beta
Measure of stock's volatility compared to the market
0.16
Shares Outstanding
Total number of shares issued by the company
₹12.25 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
4.46%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
4.31%
Payout Ratio
Percentage of earnings paid as dividends
65.29%
